The E7 Oncoprotein Is Translated from Spliced E6*I Transcripts in High-Risk Human Papillomavirus Type 16- or Type 18-Positive Cervical Cancer Cell Lines via Translation Reinitiation

Cell Nucleus 0301 basic medicine Human papillomavirus 16 Human papillomavirus 18 Transcription, Genetic RNA Splicing Retinoblastoma Down-Regulation Exons Oncogene Proteins, Viral Introns Cell Line 3. Good health DNA-Binding Proteins Repressor Proteins 03 medical and health sciences Risk Factors Humans Female RNA, Messenger Phosphorylation RNA, Small Interfering Peptide Chain Initiation, Translational
DOI: 10.1128/jvi.80.9.4249-4263.2006 Publication Date: 2006-04-12T19:38:32Z
ABSTRACT
High-risk human papillomaviruses (HPVs) encode two viral oncoproteins, E6 and E7, from a single bicistronic pre-mRNA containing three exons introns. Retention of intron 1 in the coding region is essential for production full-length oncoprotein. However, splicing extremely efficient cervical cancer cells, leading to spliced transcript, E6*I, E6. Here, we investigated whether this might benefit E7 production. Using RNA interference as tool, targeted using small interfering RNAs (siRNAs) HPV-positive cell lines. At an effective low dose, siRNAs specifically suppressed expression but not expression, demonstrated by stabilization p53. at high doses HPV18 1-specific siRNA substantially reduced level 18E6*I mRNA lacking HeLa implying its nuclear silencing on before splicing. Two other targeting exon 2 regions HPV16 -18, which oncoprotein, E6*I mRNAs remarkable extent preferentially accumulation hypophosphorylated p105Rb cycle arrest, indicating that majority proteins are translational products mRNAs. This was confirmed transient transfection 293 cells: could be translated only open reading frame (ORF) distance-dependent matter upstream ORF translation reinitiation. The data thus provide direct evidence high-risk HPVs responsible
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (190)